These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 16891860

  • 41. A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer.
    Sculier JP, Lafitte JJ, Lecomte J, Berghmans T, Thiriaux J, Florin MC, Efremidis A, Alexopoulos CG, Recloux P, Ninane V, Mommen P, Paesmans M, Klastersky J, European Lung Cancer Working Party.
    Ann Oncol; 2002 Jun; 13(6):874-82. PubMed ID: 12123332
    [Abstract] [Full Text] [Related]

  • 42. Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium.
    Long HJ, Nelimark RA, Podratz KC, Suman V, Keeney GL, Nikcevich DA, Kugler JW, Rowland KM, Kardinal CG, Wos EJ.
    Gynecol Oncol; 2006 Mar; 100(3):501-5. PubMed ID: 16185755
    [Abstract] [Full Text] [Related]

  • 43. A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer.
    Sculier JP, Lafitte JJ, Lecomte J, Alexopoulos CG, Van Cutsem O, Giner V, Efremidis A, Berchier MC, Collon T, Meert AP, Scherpereel A, Ninane V, Paesmans M, Berghmans T, European Lung Cancer Working Party.
    Ann Oncol; 2007 Jun; 18(6):1037-42. PubMed ID: 17404152
    [Abstract] [Full Text] [Related]

  • 44. The activity of gemcitabine plus cisplatin in randomized trials in untreated patients with advanced non-small cell lung cancer.
    Rosell R, Tonato M, Sandler A.
    Semin Oncol; 1998 Aug; 25(4 Suppl 9):27-34. PubMed ID: 9728582
    [Abstract] [Full Text] [Related]

  • 45. [Ifosfamide combination chemotherapy for advanced gynecologic malignancies].
    Li X, Liu L, Wu L.
    Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):330-2. PubMed ID: 11778564
    [Abstract] [Full Text] [Related]

  • 46. Vinorelbine and alternating cisplatin and ifosfamide in the treatment of non-small cell lung cancer.
    Barone C, Corsi DC, Pozzo C, Cassano A, Alvaro G, Colloca G, Landriscina M, Astone A.
    Oncology; 2000 Jul; 58(1):25-30. PubMed ID: 10644937
    [Abstract] [Full Text] [Related]

  • 47. A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer.
    Chen YM, Perng RP, Yang KY, Lin WC, Wu HW, Liu JM, Tsai CM, Whang-Peng J.
    Am J Clin Oncol; 2000 Feb; 23(1):13-7. PubMed ID: 10683066
    [Abstract] [Full Text] [Related]

  • 48. Dose-finding study of fixed dose gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients with advanced non-small cell lung cancer.
    Baka S, Manegold C, Buchholz E, Schott-von-Römer K, Lorigan P, Nagel S, Blackhall F, Aschroft L, Thatcher N.
    Lung Cancer; 2006 Aug; 53(2):165-70. PubMed ID: 16787686
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. A comparative study of cisplatin and vinblastine versus ifosfamide, cisplatin and vinblastine in non-operable non-small-cell lung cancer. A study of the Hellenic Co-operative Oncology Group for Lung Cancer Trials.
    Kosmidis P, Mylonakis N, Skarlos DV, Samantas E, Beer M, Theocharis D, Zachariadis E, Gioti A, Papadakis E, Poulakis N.
    Ann Oncol; 1994 Feb; 5(2):159-62. PubMed ID: 8186159
    [Abstract] [Full Text] [Related]

  • 53. Ifosfamide and gemcitabine: a phase II trial in advanced inoperable non-small cell lung cancer.
    Gatzemeier U, Manegold C, Eberhard W, Wilke HJ, Chomy F, Chomy P, Khayat D, Blatter J, Seeber S, Drings P.
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):15-8. PubMed ID: 9535206
    [Abstract] [Full Text] [Related]

  • 54. Micronuclei evaluation of reduction in neoadjuvant chemotherapy related acute toxicity in locally advanced lung cancer: an indian experience.
    Bahl A, Chander S, Julka PK, Rath GK, Sharma DN, Kumar A, Nair O.
    J Assoc Physicians India; 2006 Mar; 54():191-5. PubMed ID: 16800343
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.